Medications without a patient: potential lethal implications of pharmaceuticals left behind

Crisis. 2014 Jan 1;35(4):283-5. doi: 10.1027/0227-5910/a000251.

Abstract

Background: Little has been published on the sources of medications used in suicide by self-poisoning.

Aims: To examine data on self-poisoning occurring through the use of medications returned to the next of kin after the death of a family member or friend ("returned medication") and to examine public policies relevant to this issue.

Method: A review of charts at the Office of the Chief Coroner of Ontario for deaths by self-poisoning suicide in the City of Toronto occurring between 1998 and 2010 was conducted. Information regarding the source of medication used in self-poisoning was extracted. Federal, provincial, and local policies were also examined to determine whether there are guidelines governing returning medication to next of kin.

Results: Of 567 suicide deaths by self-poisoning in Toronto over 13 years, there were eight cases in which returned medication was used in suicide by self-poisoning. No policies prohibiting this type of medication return were identified.

Conclusion: Suicide by self-poisoning using returned medications is an important consideration that may not yet be fully appreciated, and has relevance for suicide prevention policies.

Keywords: policy review; self-poisoning; suicide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Overdose*
  • Drug and Narcotic Control*
  • Family*
  • Humans
  • Ontario
  • Prescription Drugs*
  • Public Policy
  • Suicide / statistics & numerical data*

Substances

  • Prescription Drugs